Predict your next investment

ALung Technologies company logo
HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
alung.com

See what CB Insights has to offer

Founded Year

1997

Stage

Debt - VII | Alive

Total Raised

$145.12M

Last Raised

$4.59M | 7 mos ago

About ALung Technologies

ALung Technologies develops intra and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. The company's current lead product under development is the Hemolung. This device is an extracorporeal gas exchange device that circulates blood via a small catheter the same size as a dialysis catheter. By directly delivering oxygen (O2) to the blood and removing carbon dioxide (CO2) from the blood, the Hemolung is expected to deliver a clinically and economically ventilation solution than mechanical ventilation. This device is capable of supporting patients with acute breathing problems for 7 days, providing their lungs a bridge to recovery.

ALung Technologies Headquarter Location

2500 Jane Street Suite 1

Pittsburgh, Pennsylvania, 15203,

United States

412-697-3370

Latest ALung Technologies News

17:00 ET USD 239.83 mn growth in Extracorporeal Membrane Oxygenation Machines Market | Evolving Opportunities with ALung Technol...

Nov 29, 2021

| 17000+ Technavio Reports News provided by Share this article Share this article Attractive Opportunities in Extracorporeal Membrane Oxygenation Machines Market by Modality and Geography - Forecast and Analysis 2021-2025 38% of the market's growth will originate from North America. US and Canada are the key markets for extracorporeal membrane oxygenation machines in the region. The rising number of new product launches will facilitate the extracorporeal membrane oxygenation machines market growth in North America  Market Dynamics Factors such as the increasing incidence of respiratory and heart failure and the growing number of transplant procedures will drive the growth of the Extracorporeal Membrane Oxygenation Machines Market. However, high costs associated with cardiac and respiratory procedures might hamper the market growth. Company Profiles The extracorporeal membrane oxygenation machines market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. The extracorporeal membrane oxygenation machines market report includes information on the product launches, sustainability, and prospects of leading vendors including ALung Technologies Inc., Eurosets Srl, Fresenius Medical Care AG, and Co. KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., and Terumo Corp. Few Companies with Key Offerings ALung Technologies Inc. - The company offers extracorporeal membrane oxygenation machines that provide ultra low flow, venovenous extracorporeal carbon dioxide removal using a single, 15.5 French dual lumen catheter inserted percutaneously in the femoral or jugular vein and removes 25 to 50 percent of basal metabolic CO2 production at circuit blood flows of 350 to 550 mL per minute, under the brand name of Hemolung RAS. Eurosets Srl - The company offers extracorporeal membrane oxygenation machines that are designed to focus on optimal gas microemboli management and of its full coating with phosphorylcholine to work in a unique range of volumes, from less than 250 ml up to 2000 ml., under the brand name of Eurosets. Fresenius Medical Care AG and Co - The company offers extracorporeal membrane oxygenation machines that enable gas exchange and circulation, respectively, when standard treatment fails thus providing clinicians time to treat patients, under the brand name of Xenios. Competitive Analysis The competitive scenario provided in the extracorporeal membrane oxygenation machines market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc. Market Segmentation By Modality, the market is classified into  Veno-venous and Veno-arterial. The extracorporeal membrane oxygenation machines' market share growth by the Veno-venous segment has been significant. By Geography, the market is classified as North America, Europe, Asia, and ROW. North America will have the largest share of the market. Related Reports - Neurodiagnostic and Monitoring Devices -The neurodiagnostic and monitoring devices market size in the US has the potential to grow by USD 443.81 million during 2020-2024. Download a free sample now! Chemiluminescence Immunoassay Analyzers Market -The chemiluminescence immunoassay (CLIA) analyzers market share is expected to increase by USD 3.24 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 10.32%. Download a free sample now! Extracorporeal Membrane Oxygenation Machines Market Scope Report Coverage Companies profiled ALung Technologies Inc., Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., and Terumo Corp. Market Dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing ALung Technologies

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned ALung Technologies in 1 CB Insights research brief, most recently on Mar 12, 2020.

Expert Collections containing ALung Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ALung Technologies is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

8,296 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

ALung Technologies Patents

ALung Technologies has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/11/2011

2/11/2014

Fluid dynamics, Fiber bundles, Differential geometry, Actuators, Algebraic topology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/11/2011

00/00/0000

00/00/0000

Grant Date

2/11/2014

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Fluid dynamics, Fiber bundles, Differential geometry, Actuators, Algebraic topology

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

ALung Technologies Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

ALung Technologies Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.